Aptus Pharma Ltd
₹482.10▲ +9.45 (+2.00%)
APPL·BSE·Consumer Goods
Market Cap
826.80 Cr
PE Ratio
179.22
Volume
11,200
Day High - Low
482.10 - 482.10
52W High-Low
482.10 - 143.00
₹482.10▲ +9.45 (+2.00%)
Market Cap826.80 Cr
PE Ratio179.22
Volume11,200
Day High - Low482.10 - 482.10
52W High-Low482.10 - 143.00
Aptus Pharma Ltd (APPL): company summary
The company's business is improving, with annual revenue rising 89.6% and annual net profit increasing 49.0%.
Aptus Pharma Ltd (APPL) is a micro-cap Consumer Goods company valued at ₹827 crore operating in Household Appliances on the NSE and BSE.
- Recent price move
- Aptus Pharma Ltd last traded at ₹482.1, up 2.00% on the day.
- Financial performance
- The company's business is improving, with annual revenue rising 89.6% and annual net profit increasing 49.0%. The latest quarter saw revenue and net profit grow 117.6% and 60.3% respectively compared to the same quarter a year earlier, though the net profit margin narrowed 2.7 percentage points to 9.9%.
- Valuation multiples
- The stock trades at 179.2 times earnings, 24.48 times book value.
- Things to watch
- The net profit margin has narrowed, which could affect profitability. The company's market cap is ₹811 crore, and the stock is at its 52-week high, with no distance below it. Promoter holding remains at 72.89%, but there are no foreign or domestic institutional holdings.
- Where it stands
- Aptus Pharma Ltd has shown strong growth in both revenue and net profit over the past year and quarter, with a 3-year profit CAGR of 189.7%. The company's return on equity and return on capital employed are positive, but the net profit margin has declined. The stock is currently at its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
5.7/10
Fair
Fair Value
Sign in to see
ROE
19.79%
Strong
P/E
179.22x
Expensive
Debt / Equity
0.31
Moderate
Industry
Consumer Goods
Household Appliances
Overall View
Mixed
Price performance
52W₹143.00
₹482.10
DocStoX take
Supported by growth (8.8) and momentum (7.5), but held back by valuation (0.0). Growth looks strong at 8.8, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence5.7
/10
Fair
Quality
Solid
ROE 19.8%
Valuation
Expensive
P/E 179.2×
Growth
Strong
Revenue +49.6% 3Y CAGR
Risk
Moderate
D/E 0.31
Momentum
Strong
100% of 52-week range
At a glance
Market Cap
₹827 Cr
52W High / Low
₹482 / ₹143
Dividend Yield
0.00%
Promoter Holding
72.89%
EPS (TTM)
₹2.69
Book Value
₹34.03
Key highlights
- Profit compounding 190% a year
- Revenue compounding 50% a year
- Profitable in all of the last 4 years
- Valuation is weak (0.0/10)
- Expensive at 179× earnings
4 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Consumer Goods stocks · Household Appliances
Explore Aptus Pharma Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Aptus Pharma Ltd peers in Consumer Goods
Other Consumer Goods stocks on the NSE & BSE. See the full Consumer Goods sector list.
Related tools & concepts
Value Aptus Pharma Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing